ENST00000385073.1:n.36C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The ENST00000385073.1(MIR27A):​n.36C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0123 in 539,264 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.012 ( 18 hom., cov: 32)
Exomes 𝑓: 0.013 ( 48 hom. )

Consequence

MIR27A
ENST00000385073.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.948

Publications

56 publications found
Variant links:
Genes affected
MIR27A (HGNC:31613): (microRNA 27a) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
MIR23AHG (HGNC:27620): (miR-23a/27a/24-2 cluster host gene)
MIR24-2 (HGNC:31608): (microRNA 24-2) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
MIR23A (HGNC:31605): (microRNA 23a) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0115 (1755/152338) while in subpopulation NFE AF = 0.0182 (1235/68024). AF 95% confidence interval is 0.0173. There are 18 homozygotes in GnomAd4. There are 821 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR27ANR_029501.1 linkn.36C>T non_coding_transcript_exon_variant Exon 1 of 1
MIR23AHGNR_036515.2 linkn.6437C>T non_coding_transcript_exon_variant Exon 1 of 1
MIR24-2NR_029497.1 linkn.-123C>T upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MIR27AENST00000385073.1 linkn.36C>T non_coding_transcript_exon_variant Exon 1 of 1 6
MIR23AHGENST00000587762.2 linkn.6447C>T non_coding_transcript_exon_variant Exon 1 of 1 6
MIR24-2ENST00000386972.1 linkn.-123C>T upstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.0115
AC:
1752
AN:
152222
Hom.:
18
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00343
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0118
Gnomad ASJ
AF:
0.0323
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0181
Gnomad OTH
AF:
0.0177
GnomAD2 exomes
AF:
0.0119
AC:
2918
AN:
245456
AF XY:
0.0121
show subpopulations
Gnomad AFR exome
AF:
0.00279
Gnomad AMR exome
AF:
0.00867
Gnomad ASJ exome
AF:
0.0337
Gnomad EAS exome
AF:
0.0000551
Gnomad FIN exome
AF:
0.00214
Gnomad NFE exome
AF:
0.0176
Gnomad OTH exome
AF:
0.0168
GnomAD4 exome
AF:
0.0126
AC:
4860
AN:
386926
Hom.:
48
Cov.:
0
AF XY:
0.0124
AC XY:
2719
AN XY:
219826
show subpopulations
African (AFR)
AF:
0.00263
AC:
28
AN:
10638
American (AMR)
AF:
0.00874
AC:
315
AN:
36046
Ashkenazi Jewish (ASJ)
AF:
0.0347
AC:
409
AN:
11786
East Asian (EAS)
AF:
0.0000718
AC:
1
AN:
13926
South Asian (SAS)
AF:
0.00544
AC:
361
AN:
66338
European-Finnish (FIN)
AF:
0.00285
AC:
94
AN:
32960
Middle Eastern (MID)
AF:
0.0279
AC:
80
AN:
2870
European-Non Finnish (NFE)
AF:
0.0171
AC:
3333
AN:
195384
Other (OTH)
AF:
0.0141
AC:
239
AN:
16978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
281
562
843
1124
1405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0115
AC:
1755
AN:
152338
Hom.:
18
Cov.:
32
AF XY:
0.0110
AC XY:
821
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00342
AC:
142
AN:
41580
American (AMR)
AF:
0.0118
AC:
180
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0323
AC:
112
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00414
AC:
20
AN:
4832
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10622
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0182
AC:
1235
AN:
68024
Other (OTH)
AF:
0.0180
AC:
38
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
85
171
256
342
427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0164
Hom.:
15
Bravo
AF:
0.0118
Asia WGS
AF:
0.00346
AC:
12
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
15
DANN
Benign
0.88
PhyloP100
0.95

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11671784; hg19: chr19-13947296; API